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ABSTRACT OF THESIS

CAUSAL ATTRIBUTIONS AND SMOKING BEHAVIORS IN CERVICAL CANCER
SURVIVORS: A MIXED-METHODS PILOT STUDY

This cross-sectional, mixed-methods study examined the nature of, and
association between, causal attributions and current smoking behavior in cervical cancer
survivors who were smokers at cancer diagnosis (n=50). As a whole, participants’ beliefs
about smoking as a risk factor or cause of cervical cancer in general (i.e., global
attribution) and/or their own cervical cancer (i.e., personal attribution) reflected far
greater endorsement of global than personal attributions. Data collection involved a
quantitative survey and an optional semi-structured interview to assess key variables (i.e.,
smoking behavior and causal attributions). Data were analyzed via descriptive statistics
and inferential tests, all of which illustrated greater endorsement of global smokingrelated causal attributions versus personal attributions within the sample. In conclusion,
the results of this formative study highlights the potential role of causal attributions in
understanding the smoking behavior of cervical cancer survivors, the results of which
aids understanding of how cancer survivors think about, and make changes in, their
smoking behavior.
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Chapter One: Introduction
Overview of Cervical Cancer
In the United States, approximately 250,000 cervical cancer survivors are alive today,
with an estimated 13,240 new cases projected for 2018 (American Cancer Society, 2018).
The nationwide incidence rate of cervical cancer is 7.4 new cases per 100,000 women
each year, and the mortality rate is 2.3 per 100,000 women (National Cancer Institute,
2018). Nationally, cervical cancer deaths have decreased significantly over the past few
decades due to more widespread adoption of Pap smear screening and human
papillomavirus (HPV) vaccination (National Institute of Health, 2013). In some regions
of the country, and for some populations, however, cervical cancer prevention and
control have not evidenced any marked improvements (Freeman & Wingrove, 2005). To
some extent, this is borne out in the state of Kentucky where the burden of cervical
cancer remains high, as indicated by an incidence and mortality rate of 8.7 and 3.0 per
100,000 women, respectively (National Cancer Institute, 2018), with an even higher
incidence and mortality rate in the state’s Appalachian regions (10.2 and 3.2,
respectively) (Hopenhayn, King, Christian, Huang, & Christian, 2008; Kentucky Cancer
Registry, 2017). Despite the relatively small number of women who must cope with
cervical cancer, this cancer should remain a key public health target because 1) it is one
of the more preventable cancers (National Cervical Cancer Coalition, 2017) and 2)
behavioral factors after cancer diagnosis can have a significant bearing on clinical
outcomes and quality of life (National Cervical Cancer Coalition, 2017; US Department
of Health and Human Services, 2014).
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Cervical Cancer and Cigarette Smoking
Cervical cancer risk is chiefly associated with HPV infection, but several other health
behaviors and related factors play a role (e.g., obesity, smoking, long-term contraceptive
use) (Stein & Colditz, 2004). Of all the behavioral factors associated with cervical cancer
risk, probably none has as significant an effect on cervical cancer prognosis as smoking.
Persistent smoking after cancer diagnosis carries considerable health risk, including
increased risk for cancer and all-cause mortality, cancer recurrence, second primary
cancer, and poorer response to and more complications after cancer treatment (US
Department of Health and Human Services, 2014). The potential for negative outcomes
among cervical cancer survivors in comparison to some other cancer survivors (e.g.,
prostate, breast, lung) may be particularly high because smoking can interact with HPV
to increase recurrence risk (Burger et al., 1996), and as alluded to above, many cervical
cancer survivors have HPV (Coker, DeSimone, Bush, Crofford, & Hopenhayn, 2009;
Schiffman, Castle, Jeronimo, Rodriguez, & Wacholder, 2007). Finally, there are data to
suggest that persistent smoking after cancer diagnosis is associated with worse quality of
life (Blanchard, Courneya, & Stein, 2008; Browning, Wewers, Ferketich, Otterson, &
Reynolds, 2009; Frumovitz et al., 2005; Piper, Kenford, Fiore, & Baker, 2012).
Despite the clear clinical significance of the behavior, only a handful of studies have
explored the prevalence of current smoking (or any other tobacco use) among cervical
cancer survivors. This is likely due to the fact that cervical cancer is not viewed as a
“smoking-related cancer” in the same way as lung or head/neck cancer, for example
(American Cancer Society, 2018). That said, available data suggests the prevalence of
current smoking among cervical cancer survivors is quite high, with estimates from US
population-based and other large studies in the range of 40 to 50% (Brinton et al., 1986;
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Coker, DeSimone, Eggleston, et al., 2009; Coups & Ostroff, 2005; D. K. Mayer &
Carlson, 2011). In sum, the burden of cervical cancer can be compounded by the health
risk behavior of persistent smoking, which can have a meaningful impact on the lives of
cervical cancer survivors.
Causal Attributions: Theories and Applications for Cancer
Cancer has many causes, and it is often the case that the cause of any given cancer
is unknown. Nonetheless, the beliefs that cancer survivors hold regarding what caused
their cancer, or what causes cancer in general, can have a significant bearing on their
health behavior performance and change. Several health behavior theories (namely, the
Health Belief Model, Attribution Theory, and Theory of Planned Behavior) generally
suggest that individuals who believe there are risks associated with their past or current
behavior will try to adopt health-promoting behaviors – if they are sufficiently motivated
to do so (Ajzen, 1991; Ajzen & Fishbein, 1980; Heider, 1958; Hochbaum, 1958;
McBride, Emmons, & Lipkus, 2003; Weiner, 1985). Causal attribution models, in
particular, explain that individuals who experience an unexpected negative event
typically attempt to find a causal explanation for it, and then try to change their behavior
and/or environment to prevent any future risks to their health or well-being (Hall, French,
& Marteau, 2003). These models also suggest that individuals tend to categorize potential
causes as either external (i.e., a situation, event, or stimulus outside one’s control) or
internal (i.e., a trait or characteristic within the individual) (Ferrucci et al., 2011; Weiner,
1985), a difference that is theorized to change the amount of responsibility, need for
coping, and risk to self-concept experienced by the person (Callebaut, Molyneux, &
Alexander, 2016). As it pertains to a negative health event like a cancer diagnosis, causal
attributions may determine how individuals adjust to their illness and what steps they
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take to promote their health (Callebaut et al., 2016; Ferrucci et al., 2011).
Causal Attributions: Global versus Personal
When asked to identify causes of, or risk factors for, cancer in general (i.e., global
attributions), cancer survivors consistently identify genetics, other individual-level factors
like smoking and obesity (Liang, Chen, & Giovannucci, 2009; Mullens, McCaul,
Erickson, & Sandgren, 2003; Torre et al., 2015), and environmental factors (e.g.,
pollution, sun exposure, and second-hand smoke) (Ferrucci et al., 2011; Lykins et al.,
2008; Mullens et al., 2003; Rodriguez et al., 2015; Wold, Byers, Crane, & Ahnen, 2005).
While cancer survivors’ global attributions usually have some degree of accuracy, the
causal list typically generated is incomplete, as there is oftentimes little endorsement of
physical inactivity (Gritz et al., 2006) and poor diet (Lykins et al., 2008) among other
known risk factors for cancer. Also noteworthy is that while the majority of cancer risk
stems from individual-level (and largely behavioral) factors (Willcox, Stewart, & Sitas,
2011), environmental factors are reported at least as frequently as the former (Wold et al.,
2005). Overall, the literature on global attributions suggests there is still room for
improvement when it comes to cancer survivors’ knowledge of what contributes to
cancer.
As mentioned above, cancer survivors can accurately identify some of the
definitive causes of cancer in general; however, when asked to identify causes of their
own cancer (i.e., personal attributions), the veracity of their beliefs is arguably less
because stress and/or “God’s will” are often reported as some of the foremost causes
(Costanzo, Lutgendorf, Bradley, Rose, & Anderson, 2005; Richman, Troutman, &
Torres, 2016; Sterba, Zapka, LaPelle, Armeson, & Ford, 2015; Willcox et al., 2011;
Wold et al., 2005). In samples of gynecologic cancer survivors, in particular, some of the
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more well established causes of cancer are routinely linked more closely to cancer in
general than to survivors’ own cancer (Costanzo et al., 2005; Stewart et al., 2001). For
example, when asked about smoking, both current and former smokers agreed that
smoking might have contributed to their cancer, but current smokers were more likely to
believe that smoking was a greater risk factor for other people (Weinstein, Marcus, &
Moser, 2005; Wold et al., 2005). It is possible that apparent disconnects like this are a
form of self-protection, insofar as the admission of one’s role in causing one’s cancer
could carry with it some negative effects (e.g., shame, guilt, despair). Nonetheless, the
discordance between global and personal causal attributions creates a situation wherein
cancer survivors may underestimate the clinical significance of their own health behavior
change.
Causal Attributions: Cervical Cancer and Smoking
Many cervical cancer survivors lack knowledge about the causes of cervical
cancer (Akinlotan et al., 2017; Low, Simon, Lyons, Romney-Alexander, & Waller,
2012). Remarkably, cervical cancer survivors tend not to endorse smoking as a cause of
cervical cancer, whether of their own cancer, or cancer in general. For example, one
study found that gynecologic cancer survivors believe stress is a more powerful risk
factor for cancer than smoking and several other known causal factors (Costanzo et al.,
2005). While only a handful of studies have looked at cervical cancer specifically, the
consensus is that this population has high unmet need when it comes to health
information (Brinton et al., 1986; Coker, DeSimone, Eggleston, et al., 2009; Collins,
Rollason, Young, & Woodman, 2010; Costanzo et al., 2005; Marteau, Rana, & Kubba,
2002; Plummer et al., 2003; Roura et al., 2014; Schlumbrecht, Sun, Huang, Zandstra, &
Bodurka, 2014a). Unfortunately, healthcare providers often fail to educate their patients
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about the robust benefits of health behavior change (Lindau et al., 2002; Mayer et al.,
2007; Underwood et al., 2012), including smoking cessation after cancer diagnosis
(Warren, Sobus, & Gritz, 2014; Weaver et al., 2012). This missed opportunity undercuts
efforts at secondary cancer prevention and general health promotion (Grimmett, Wardle,
& Steptoe, 2009; Parsons, Daley, Begh, & Aveyard, 2010; Wold et al., 2005).
Specifically, for cancer survivors who smoke, and particularly so for cervical cancer
survivors, it is possible that fostering beliefs in smoking as a causal attribution could lead
to efforts at smoking cessation, which if successful, could ultimately lead to measurable
reductions in health risk and improvements in well-being.
Study Aims and Hypotheses
In a sample of cervical cancer survivors who were smokers at the time of their
diagnosis, this mixed-methods pilot study first aims to describe, and then measure the
relationship between, a) smoking-related causal attributions about cervical cancer and b)
current smoking behavior. Regarding causal attributions, both global and personal causal
attributions will be measured, as a first step to determining if participants believe the
cause of their cervical cancer is similar to or different from the cause of other women’s
cervical cancer. Regarding smoking behavior, several outcomes will be considered
including overall prevalence of current smoking, frequency and amount of smoking, and
motivation to quit/abstain from smoking. All analyses for the first aim (i.e., to describe
causal attributions and smoking behavior) will be descriptive in nature, with use of both
qualitative and quantitative data. In contrast, analyses for the second aim (i.e., to measure
the relationship between causal attributions and smoking behavior) will include
inferential tests of pertinent quantitative data plus content analysis of qualitative data. In
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sum, the mixed-method study design lends itself to use to complementary and
simultaneous use of qualitative and quantitative data analysis.
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Chapter Two: Methods
Participants and Procedure
Population and Eligibility. Participants were 50 cervical cancer survivors
currently living in the state of Kentucky who were diagnosed with a first primary cervical
cancer in the past five years. Additional eligibility criteria were: 1) Kentucky residence at
diagnosis, 2) age over 21 at the time of enrollment, 3) English literacy and fluency, 4)
diagnosis between the age of 21 and 55, 5) lifetime smoking history (i.e., having smoked
more than 100 cigarettes), 6) smoking at diagnosis according to a 3-month point
prevalence definition, 7) reliable phone access, 8) not being pregnant or planning to
become pregnant in the 6 months following enrollment, 9) having no cognitive or
psychological impairments or diagnoses, and 10) no prior cancer diagnoses (excluding
melanoma).
Recruitment and Enrollment. Participants were recruited through a combination of
population sampling (Kentucky Cancer Registry, KCR) and purposive sampling
(Kentucky Cancer Link, KCL). KCR is a statewide, population-based cancer registry that
is part of the Surveillance Epidemiology and End Results (SEER) system and the CDC’s
National Program of Cancer Registries. KCL is a statewide organization that provides
access to cancer-related screening, services, and support (e.g. mastectomy garments,
wigs, patient navigation, transportation, smoking cessation classes) to low-resource
residents in Kentucky, that is, uninsured or underinsured adults who fall below the
Federal Poverty Line (Kentucky Cancer Link, 2017). The use of both KCR and KCL was
intended to produce a sample of cervical cancer survivors who were representative of the
population at the state level and who would benefit most from future resource
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dissemination related to smoking cessation (Adler et al., 1994; Coups & Ostroff, 2005;
Ward et al., 2010).
Potentially eligible cervical cancer survivors (i.e., those who had a documented
lifetime history of tobacco use and Kentucky residence at diagnosis) were given the
opportunity to opt-in to study participation through invitations sent directly by
KCR/KCL. At this stage of recruitment, cancer survivors were informed that they might
be eligible to participate in a research study, but only a very brief description of the study
was provided. For KCR, the first step involved physician notification and attainment of
his or her approval to contact the cancer survivors. If warranted, the second step involved
cancer survivor notification, where cancer survivors were asked to indicate whether or
not they approve of their contact information being released to study staff. At this step,
cancer survivors were contacted by mail and/or phone in order to gain their approval. For
KCL, the same approach was used, but cancer survivors were contacted directly without
physician involvement. In the case of both KCR and KCL, a research assistant only
attempted to contact cancer survivors who “opted in” to study consideration.
Once research assistants received the names and contact info for all cancer
survivors who “opted in,” they attempted to contact them via phone to screen them for
eligibility. Ineligible cancer survivors were thanked for their time and not contacted
further. Eligible cancer survivors were informed about the study in greater depth and
asked if they would like to participate. If eligible and interested, an attempt was made to
enroll cancer survivors into the study via attainment of written informed consent. Once
enrolled into the study, the procedures for data collection commenced. In cases where
cancer survivors were not reached via phone, research assistants tried to reach them via
mail and engage them in study participation via that route.
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Data Collection. Data collection consisted of two parts. First, a standardized
questionnaire was completed either via a phone interview with a research assistant or a
mailed paper-and-pencil form. For both methods of data collection, de-identified data
were entered and stored securely in a REDCap database to preserve participant privacy
and confidentiality. Second, participants were invited to complete a brief semi-structured
interview via phone, an opportunity for them to explain their experiences of smoking (or
quitting) after cervical cancer in their own words. A standardized interview guide was
used, with the nature and number of follow-up or “targeted” questions tailored to each
participant’s response to the core set of open-ended questions (Hsieh & Shannon, 2005).
Interview data were recorded and transcribed verbatim, with all relevant files deidentified to preserve participant privacy and confidentiality. The questionnaire took
approximately 35 minutes to complete, and the interview generally lasted 25 minutes.
Compensation. Participants were compensated $45 for questionnaire and $30
interview completion. Payments were made via check mailed to participants’ home
address.
Ethical Approval. All procedures were reviewed and approved in advance of
implementation by the University of Kentucky Institutional Review Board and Markey
Cancer Center Protocol Review and Monitoring Committee.
Measures
Demographics. Standard items were used to assess participants’ demographic
background (e.g., age, race, relationship status, education level). Items were primarily
taken from a recent Behavioral Risk Factors Surveillance System survey (Centers for
Disease Control and Prevention, 2015), a yearly population-based health survey of noninstitutionalized adults in the United States.

10

Clinical History. KCR provided the following pieces of information about each
participant: time since cancer diagnosis, age at diagnosis, site and stage of cancer
diagnosis, type of treatment, recurrence status, and insurance status.
Causal Attributions. Causal attributions about cervical cancer were measured
from both a global and personal perspective, all with a focus on smoking as an etiological
factor. First, two items on the questionnaire tap causal attributions. One item from the
Cervical Cancer Objective Test (Ralston et al., 2003) was used to assess global
attributions of cervical cancer: “The risk of developing cervical cancer is higher if
someone is a smoker”. Participants were asked to indicate whether this statement is false
(0) or true (1). Similarly, one item from the Perceived Cancer Related Stigma Scale
(LoConte, Else-Quest, Eickhoff, Hyde, & Schiller, 2008) was modified to measure
personal attributions of cervical cancer: “My smoking or other tobacco use contributed to
my cancer”. Participants responded to this item on a Likert scale from 1=strongly
disagree to 5=strongly agree, which was later dichotomized to reflect disagreement (0) or
agreement (1). Second, causal attributions were measured through interview questions
about the extent to which participants believe smoking impacts cervical cancer (e.g.,
“What role, if any, do you believe that smoking has in cervical cancer?”).
Smoking Behavior. Smoking behavior was measured via a combination of
questions that are regularly used in research with the general population of smokers (Bolt
et al., 2009; Centers for Disease Control and Prevention, 2015; Heatherton, Kozlowski,
Frecker, & Fagerstrom, 1991) and specifically among cancer survivors (Land et al.,
2016). In the questionnaire, smoking behavior was assessed in a comprehensive fashion.
First, 30-day and 7-day point prevalence of current smoking were determined at the
sample level. Second, and only among current smokers, the frequency (i.e., how often)
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and amount (e.g., average number of cigarettes per day in the past week as reported via
time-line follow-back) of smoking and level of nicotine dependence (as measured by the
Heaviness of Smoking Index (Heatherton et al., 1991) were explored, among other
things. Additionally, in the full sample, several components of quit behavior were
examined, including: 1) motivation and confidence to quit or maintain abstinence over
the next 30 days, as measured on a scale from 0=very definitely no to 10=very definitely
yes; 2) prevalence and number of 24-hour quit attempts since cancer diagnosis; and 3) use
of smoking cessation treatment since cancer diagnosis. In the interview, smoking and quit
behavior were measured (e.g., “How much and how often did you smoke before and after
your diagnosis?” and “What approaches did you use to quit or cut back?”).
Data Analysis
Data analysis employed use of quantitative and qualitative methods for the questionnaire
and interview data, respectively. First, for the questionnaire data, descriptive statistics
(e.g., prevalence, frequency, mean, standard deviation) were used to determine the extent
of endorsement of smoking as a cause of cervical cancer on global and personal levels.
These same statistics were used to describe thoroughly the sample’s smoking (i.e.,
prevalence, frequency, amount, and motivation to quit/abstain) and quit (i.e., prevalence,
number, and method of quit attempts post-cervical cancer diagnosis) behavior.
Additionally, chi-square (2) and bivariate correlation (Spearman’s rho) analyses of
questionnaire data were performed as an initial test of the association between causal
attributions and smoking behavior. Second, interview responses that address the issue of
causal attributions, smoking and other tobacco use status, and the link between these
variables were explored. These analyses involved directed content analysis (Hsieh &
Shannon, 2005), where prior research and theories pertinent to causal attributions helped
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guide analysis. This analysis involved many steps: 1) reading, re-reading, and then
discussing with several co-investigators a random selection of interviews (n=7); 2)
identifying key concepts or variables as initial codes; 3) organizing the initial codes into a
draft codebook (see Table 1) and creating operational definitions for each code; 4)
double-coding (i.e., independent coding by two individuals, with discrepancies among
codes discussed and rectified to achieve a “final” set of agreed upon codes for each
interview) the aforementioned interviews via line-by-line coding (Charmaz, 2006); 5)
finalizing the codebook, which involved hierarchical organization with “lumping” or
“splitting” some of the initial codes and adding new codes; 6) revising the previously
coded interviews (n=7) to reflect the final codebook; 7) double-coding all remaining
interviews (n=14) consistent with the final codebook; and 8) entering and analyzing all
coded interviews (n=21) in ATLAS.ti version 8 (Berlin, Germany).
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Table 1
Codebook for qualitative data analysis: Smoking-related causal attributions of cancer
Variable/Code
Operational Definition
Illustrative Quotes
Smoking Causes Cancer in General – Global Casual Attributions
Smoking directly caused, or is a significant risk
Yes, it does
“I know that, you know, smoking does cause
factor for…
cancer.” (148)
…Cervical cancer
Maybe, it’s possible
“I really didn’t correlate the whole smokin’ and
…Head, neck, or lung cancer
cancer…but it’s hit home a little bit more.” (100)
…Any type of cancer
No, it doesn’t
“I don’t think smoking’s got anything to do with
any type of cancer, in my personal opinion.” (106)
I don’t know
“I really can’t say yes on that one, ‘cause I really
don’t know if it would be or not.” (120)
Smoking Caused My Cervical Cancer – Personal Casual Attributions
Smoking directly caused, or is a significant risk
Yes, it did
“I’ve only heard that it’s not good to smoke…that
factor for participant’s own cervical cancer
that’s one of the causes…so I knew that was
another, you know, thing that wasn’t very good
for it.” (143)
Maybe, it’s possible
“I’m still not sure that it had anything to do
with the cervical cancer, but I don’t know.
That’s a possibility.” (137)
No, it didn’t
“I don’t believe it had any role as far as the
cervical cancer.” (142)
I don’t know
“Maybe it’s because I did smoke, I don’t smoke.”
(127)
Smoking Status - Current
Former smoker who quit at one point after cancer
Former, with continuous
“Last year I went through cervical cancer. I
diagnosis and never smoked again
abstinence
stopped smokin’ and stopped drinkin’.” (149)
Former smoker who quit at one point after cancer
Former, with lapses
“I couldn’t even tell you how long it’s been since
diagnosis, but smoked a handful of times
I had a cigarette, it’s been so long.” (100)
Current smoker who made 4 or more QA1 after
Smoker, with many QA
“I’d like to try to quit smoking. I’ve tried so
cervical cancer diagnosis
many times, it’s just nothing works!” (120)
Current smoker who made 1-3 QA after cervical
Smoker, with a few QA
“I went back to smokin’, but it was like a while
cancer diagnosis
after the treatment.” (152)
Current smoker who made 0 QA after cervical
Smoker, with no QA
“I think I smoke probably more now that I did
cancer diagnosis
before and that’s crazy! Because you think I
would wanna quit.” (127)
Note: QA= Quit attempt1. Options are mutually exclusive.

Chapter Three: Results
Sample Accrual
The details of accrual can be found in Figure 1. As shown, KCR and KCL
identified 268 and 48 potentially eligible survivors, respectively. Of those identified by
KCR, 34.3% (n=92) consented to study contact, 60.6% (n=63) of whom were
successfully reached and screened. Of those screened, 71.4% (n=45) met eligibility
criteria, with the most common reason for ineligibility being denial of tobacco use at
diagnosis. Finally, the enrollment rate of those eligible was 91.1% (n=41). Of those
identified by KCL, 50.0% (n=24) consented to study contact, 70.8% (n=17) of which
were successfully reached and screened. Of those screened, 76.5% (n=13) met eligibility
criteria, with the only reason for ineligibility being a denial of tobacco use at diagnosis.
Finally, the enrollment rate of those eligible was 92.3% (n=12). In total, 53 individuals
enrolled in the study, but 5.7% (n=3) were lost to follow-up, which means they provided
written informed consent but did not furnish any study data. Therefore, our final sample
consists of 50 cervical cancer survivors.
Sample Characteristics
Demographic Variables. A clear majority (94.0%, n=47) of this entirely female
sample was White, non-Hispanic. On average, participants were 45.5 (SD=8.1) years old.
Roughly half of participants were in a relationship (46.0%, n=23), but many selfidentified as divorced (20.0%, n=10) or separated (10.0%, n=5). Many participants
reported having less than a high school education (38.0%, n=19), with very few having
completed a college degree (8.0%, n=4). Nearly two-thirds of participants were
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unemployed (64.0%, n=32), and related to that, roughly half of their annual household
income fell under $20,000 per year (54.0%, n=27). Finally, a majority of participants
indicated rural or Appalachian residence at the time of study participation (60.0%, n=30).
More details about participants’ demographic characteristics can be found in Table 2.
Clinical Variables. The average age at diagnosis was 42.8 (SD=8.0) years old,
with the average time since diagnosis being 2.7 years (SD=1.3). Stage of cancer at
diagnosis spanned from Stage I (56.0%, n=28) to Stage IV (2.0%, n=1). Many
participants received multimodal treatment (60.0%, n=30), with the most common
treatment regimen among these patients consisting of surgery, radiation, and
chemotherapy (30.0%, n=15). At the time of recruitment, 68.0% (n=34) of the sample
was disease-free. Very few (6.0%, n=3) participants reported an absence of insurance
coverage; the most common coverage was Medicaid (48.0%, n=24). More details about
the clinical composition of the sample are available in Table 3.
Aim 1: Causal Attributions
This study involves a description of smoking-related causal attributions among cervical
cancer survivors who smoked at diagnosis. Data on participants’ causal attributions are
pulled from both the questionnaire and interview, and the next two sections reflect
analysis of each of these aspects of this mixed-methods pilot study.
Questionnaire Results. Sixty-four percent (n=32) of participants agreed with a statement
about the risk of developing cervical cancer being higher if someone is a smoker. This
would suggest many of the cervical cancer survivors in this study conceptualize smoking
as a risk factor for, or cause of, cervical cancer in general. However, when asked about
the extent to which they believed their smoking (or other tobacco use) contributed to
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their cervical cancer, only 28.0% (n=14) “agreed” or “strongly agreed.” Given the
different levels of endorsement between global and personal attributions as they pertain
to smoking and cervical cancer, crosstab analyses were run to explore further these
outcomes. Thirty-four percent (n=17) of the sample endorsed neither global nor personal
attributions, 26.0% (n=13) endorsed both global and personal attributions, and the
remainder endorsed global attributions alone (38.0%, n=19) or personal attributions alone
(2.0%, n=1).
Interview Findings. Participants who completed the interview (n=21) responded to this
open-ended question: “What role, if any, do you believe that smoking has in cervical
cancer?”. The most common response to this question reflected participants being
completely unaware or unsure of the causal link between smoking and cervical cancer in
general (i.e., global attributions):
“You know, I really don’t know. I mean, I thought the
reason why I got the cervical cancer because I had the
HPV virus. They said that some, most women get it, but it
normally will just go away, ‘cause the body fights it and I
guess mine didn’t. And maybe that’s because I did smoke,
I don’t know.” (127)
“I don’t know if, I don’t know if it even plays a role in
it. I’m not sure.” (137)
“Well, nobody had ever really told me anything about it
at all, about they go hand-in-hand or nothin’.” (144)
In comparison to the more common endorsement of uncertainty, a clear minority of
participants firmly believed smoking to be associated with cervical cancer risk in general,
while some participants remarked that smoking has no association with cervical cancer:
For example, one participant said, “It plays a big part. I didn’t start smoking until I was
thirty. And when I found out that I had cervical cancer, the doctor told me to stop
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smokin’.” (149), while others made comments like “I don’t believe it plays any [role] in
cervical cancer” (142) and “there’s so many people that get cancer who never smoked or
anything, so I don’t really think it’s linked to smoking.” (126). Participants’
understanding of the association between smoking and cervical cancer was in stark
contrast to their comments about the connection between smoking and “traditional”
smoking-related cancers like lung and oral cavity cancer, or the risks of smoking for
health in general.
“I mean, it does [have to do] with lung cancer and throat
cancer, but cervical cancer? No.” (137)
“I don’t believe it plays any [role] in cervical cancer…now
lung cancer, something like that…is a different story” (142)
“Cigarettes are known to cause cancer anyways…so if it is,
it’s probably not cervical cancer. It’s probably lung cancer
or somethin’ like that, I don’t know.” (156)
“With all the, you know, negative effects that smoking can
have on people. I mean, not just cancer, but you know,
heart disease, emphysema, I mean…you’d be crazy to pick
up a cigarette and smoke.” (148)
In terms of participants’ causal attributions about their own cervical cancer (i.e., personal
attributions), few spoke in a manner that suggested their smoking might have a role in
their cancer diagnosis. As examples of personal attributions, one participant said, “I got
cervical cancer, and I smoked, and I’m still smoking. It was a huge part.” (121).
Similarly, “I felt guilty every time I lit a cigarette up after I knew I had cancer, because I
knew that it contributed to the cancer” (108). The more common responses to questions
of personal attributions reflected either uncertainty or disbelief that smoking caused or
increased risk related to their personal cancer experience. One participant said, “I don’t
even know how it really came about, you know? …That’s the one thing I never really
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found out” (152), with another saying, “I don’t think that I would have to worry about
catchin’ cervical cancer again…smoking causes a lot of different stuff but didn’t have
nothin’ to do with any of that” (131). In sum, participants’ global and personal
attributions as measured via interview reflect great diversity of opinion.
Aim 1: Smoking and Other Tobacco Use Behavior
This study also involves a description of the tobacco use behavior of cervical cancer
survivors who smoked at diagnosis. Data on participants’ smoking and non-cigarette
tobacco use reflect questionnaire and interview responses alike while all other smokingrelated outcomes (e.g., motivation to quit/abstain) are confined to questionnaire data.
Questionnaire Results for Smoking Behavior. Consistent with inclusion criteria, all
participants endorsed a lifetime history of cigarette smoking, which was defined as ever
having smoked at least 5 packs or 100 cigarettes in total. In addition, and also a
consequence of the inclusion criteria, all participants reported smoking within the month
prior to their cervical cancer diagnosis. In terms of current smoking behavior as measured
via questionnaire, the 30-day point prevalence rate of smoking was 79.5% (n=39/49
respondents), which is very similar to, but not exactly the same as the 7-day point
prevalence rate of smoking (77.1%, n=37/48 respondents). When asked the precise
number of days they smoked in the past 30 days, participants’ responses ranged from 0
(22.0%, n=11) to 30 (62.0%, n=31), with daily smoking being the modal response. In
sum, at the time of study participation, the clear majority of the sample could be
described as regular smokers. Current smokers reported smoking an average of 16.5
(SD=8.7) cigarettes per day, and nearly three-quarters reported smoking their first
cigarette of the day within 30 minutes of waking (71.0%, n=27). Based on the Heaviness
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of Smoking Inventory (Heatherton et al., 1991), the average level of nicotine dependence
among current smokers was 2.7 (SD=1.5), which falls into the moderate range.
Questionnaire Results for Non-Cigarette Tobacco Use. Roughly half of those who
reported a 30-day point prevalence of cigarette smoking (i.e., “current” smokers) also
reported a 30-day point prevalence of non-cigarette tobacco use (43.6%, n=17). The
nature of smokers’ dual tobacco use (or in some cases multi-tobacco product use) was as
follows: 15.4% (n=6) electronic cigarettes; 12.8% (n=5) cigars or pipes; 2.6% (n=1)
chewing tobacco or moist snuff; 2.6% (n=1) Swedish-style snus; options not mutually
exclusive. It should also be noted that while none of the former smokers reported a 30day point prevalence of non-cigarette tobacco use, a minority did endorse a lifetime
history of non-cigarette tobacco use (18.2 %, n=2).
Interview Findings on Smoking and Non-Cigarette Tobacco Use. For the 21 participants
who completed the interview, 71.4% (n=15) described themselves in ways consistent
with being a current smoker or other tobacco user. For example, one participant stated,
“Even everything I went through, I still smoke” (114). Similarly, another participant
remarked, “I don’t enjoy it per se, but it’s relaxing to me…and to a degree it’s more
stressful, ‘cause you know, I know the risk that I’m taking. I know what I’m doing to my
body” (153), and still another said, “I still smoke every now and again. It’s a stress
reliever for me” (148). A small number of participants reported use of another tobacco
product in combination with, or instead of, conventional cigarettes. For example, “I
started using…the electronic, and I do use that, like, twice a month” (100). The remaining
participants (28.6%, n=6) described themselves as former smokers: “It was such a
freedom to and relief to be finally free from that” (108); “The big part of why I did
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recover is because I stopped smoking” (149); and “I’m an ex-smoker” (113). As a whole,
the prevalence of continued tobacco use among cervical cancer survivors who were
smokers at diagnosis was comparable across the questionnaire and interview data.
Motivation and Confidence to Quit or Abstain from Smoking. Across the total sample,
intention and confidence to quit/abstain in the next month were both low (M, SD=4.3, 3.9
and 4.3, 4.0, respectively, both on a 0-10 scale). These variables were positively
correlated with each other at the sample level: r=0.52, p<0.001. There was a significant
difference (t (47) =3.10, p=.003) between the level of intention to quit among current
smokers (M, SD=3.5, 3.2) and the level of intention to maintain abstinence among former
smokers (M, SD=7.3, 4.7), such that a more favorable response was found among former
smokers. Similarly, the level of confidence to quit among current smokers (M, SD=2.7,
3.1) and the level of confidence to maintain abstinence among former smokers (M,
SD=9.8, 0.6) differed significantly from each one another and suggested that former
smokers were more confident: t (47) =7.6, p=.000.
Quitting Preferences and Behavior. Across the sample, the majority of participants
indicated a desire to quit smoking without the help of professionals (64.0%, n=32) or
medications like NRT, Zyban, or Bupropion (58.0%, n=29); options mutually exclusive.
Most current smokers (61.5%, n=24) preferred to quit without professional help but were
nearly evenly divided on whether they wanted to quit without the aid of medication
(51.3%, n=20); options mutually exclusive. In comparison, former smokers
overwhelmingly preferred to quit without either professional help (72.7%, n=8) or
medication (81.8%, n=9), perhaps a testament to the approach that yielded their current
state of abstinence from smoking.
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A lifetime history of serious quit attempts (defined as any 24-hour quit attempts) was
high for the total sample (90.0%, n=45). Post-cancer diagnosis, 60.0% (n=30) of the
sample reported having made at least one 24-hour quit attempt, which reflects 61.5%
(n=24) of current smokers and all former smokers (n=11). The average number of 24hour quit attempts post-cancer diagnosis was 2.7 (SD=3.8; range: 0-20) at the sample
level, 2.8 (SD=4.2; range: 0-10) for current smokers, and 1.8 (SD=1.2; range: 1-4) for
former smokers. Former smokers reported having been abstinent from smoking, on
average, for over a year (M=469.7±388.5 days), although half quit in the year (36.4%,
n=4) or month (9.1%, n=1) before questionnaire completion. Some current smokers
reported making 24-hour quit attempts in the past year (51.3%, n=20), and among those
who tried to quit, the average number of attempts was 1.96 (SD=1.9; range: 1-8).
Details about participants’ treatment use can be found in Table 4 and is summarized here.
Within the total sample, 60.0% (n=30) indicated ever having used an evidence-based
treatment for smoking cessation (e.g., nicotine replacement therapy, quit line). This
utilization rate corresponds to 64.1% (n=25) of current smokers and 45.5% (n=5) of
former smokers. As indicated above, half of the former smokers quit more than a year
prior to study participation; thus, more details about treatment utilization will be reserved
for current smokers. Eighty percent (n=16) of current smokers who tried to quit in the last
year reported doing so with the help of an evidence-based cessation treatment. In the
context of these current smokers’ quit attempts (n=16), these treatments were utilized:
50.0% physician consultation (n=10); 95.0% nicotine replacement therapy (n=19); 25.0%
Chantix (n=4); and 12.5% Bupropion (n=2); options not mutually exclusive.
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Aim 2. Association between Causal Attributions and Smoking Behavior
For the questionnaire data, a chi-square analysis of independence was used to explore the
association between causal attributions and smoking status. This analysis indicated 68.4%
(n=26) of current smokers compared 50% (n=6) of former smokers agreed that smoking
increases the risk of cancer in general. This difference in global attributions did not yield
a statistically significant result: 2(1)= 1.34, p=0.25. A parallel analysis of personal
attributions indicated that 26.3% (n=10) of current smokers as opposed to 33.3% (n=4) of
former smokers agreed that their smoking contributed to their cancer. Again, the group
difference was not statistically significant: 2(1)= 0.22, p=0.64. Additionally, a
Spearman’s rank-order analysis (rho) was run to assess the relationship between
participants’ causal attributions and intention to quit/abstain from smoking. The results of
this analysis demonstrated a small, positive association for global attributions (rho=0.27,
p=0.06) and a weaker, but still positive association for personal attributions (rho=0.12,
p=0.42), neither of which was statistically significant.
From the interview data, a clearer pattern was evident, such that current smokers
admitted the harms of smoking, but generally minimized its contribution to their cancer
diagnosis while former smokers were more inclined to admit the harms in general and the
personal impact on their health and wellbeing. To summarize, almost without exception,
all participants endorsed some degree of belief that smoking has a long-lasting, negative
impact on overall health and health-related quality of life, which was in contrast to
comparably low participant endorsement of the role that smoking has in cervical cancer
specifically. As illustrated above in both the questionnaire and interview data, many
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participants endorsed global causal attributions for cervical cancer or cancer at other sites
while few reported personal causal attributions.

24

Table 2
Demographic characteristics of cervical cancer survivors (N=50)
Variable
% (n)
1
Age in years
45.53  8.08
Race
Caucasian, non-Hispanic
94.0 (47)
African American
6.0 (3)
Relationship status
Single: never married
14.0 (7)
Single: divorced, separated, or
38.0 (19)
widowed
Married or partnered
46.0 (23)
Missing
2.0 (1)
Educational attainment
Less than high school graduation
38.0 (19)
High school graduate or equivalent
18.0 (9)
Some college or technical school
36.0 (18)
College or technical school graduate
8.0 (4)
Employment
Employed
36.0 (18)
Unemployed
64.0 (32)
Disabled
34.0 (17)
16.0 (8)
Unemployed  1 year
Unemployed < 1 year
4.0 (2)
Homemaker
8.0 (4)
Retired
2.0 (1)
Geographic residence
Urban or suburban
36.0 (18)
Rural
60.0 (30)
Missing
4.0 (2)
Appalachian residence
Yes
35.8 (19)
No
64.2 (34)
Annual household income
Less than $10,000
24.0 (12)
$10,000 to $19,999
30.0 (15)
$20,000 to $34,999
14.0 (7)
$35,000 to $49,999
10.0 (5)
$50,000 to $74,999
6.0 (3)
$75,000 or more
10.0 (5)
Missing
6.0 (3)
1
Note. Data are % (n) unless otherwise noted. Data are means ± standard deviations.
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Table 3
Clinical characteristics of cervical cancer survivors (N=50)
Variable
Percent
1
Years since diagnosis
2.70  1.28
1
Months since treatment
31.41  15.64
Age at diagnosis
42.78 7.96
Cancer site
Cervical
98.0 (49)
Other
2.0 (1)
Cancer stage
I
56.0 (28)
II
20.0 (10)
III
22.0 (11)
IV or metastatic
2.0 (1)
Treatment type
Surgery only
32.0 (16)
Radiation only
2.0 (1)
Radiation and chemotherapy
28.0 (14)
Surgery and radiation
2.0 (1)
Surgery, radiation, and chemotherapy
30.0 (15)
Other
6.0 (3)
Recurrence status
No
68.0 (34)
Yes
6.0 (3)
Never disease-free
24.0 (12)
Missing
2.0 (1)
Insurance status
Not insured
6.0 (3)
Insured Private
34.0 (17)
Tricare
2.0 (1)
Medicaid
48.0 (24)
Medicare
2.0 (1)
Insured other
8.0 (4)
Note. Data are % (n) unless otherwise noted. 1 Data are means ± standard deviations.
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Table 4
Lifetime use of smoking cessation treatment (N=50)
Prevalence (%) by smoking status
Sample
Current
Former
(N=50)
(n=38)
(n=12)
Any treatment
92.0
68.4
41.7
1
NRT medications
Patch, gum or lozenge
54.0
63.2
25.0
Nasal spray or inhaler
10.0
13.2
0.0
Non-NRT medications 1
Varenicline
30.0
31.6
25.0
Bupropion
18.0
21.1
8.3
Behavioral treatments 1
Quitline counseling
14.0
15.8
8.3
Other counseling
8.0
10.5
0.0
Physician consult
50.0
52.6
41.7
Note. NRT= Nicotine Replacement Therapy; 1 Options not mutually exclusive
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Figure 1
Study Flow Chart.
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Chapter Four: Discussion
Cervical cancer is undeniably and predominately associated with HPV infection
(Schiffman et al., 2007; Waggoner, 2003), but research has also demonstrated causal
links between smoking and cervical cancer (Coker, DeSimone, Bush, et al., 2009; Mayer
& Carlson, 2011; Plummer et al., 2003). Smoking after cervical cancer diagnosis, as is
the case with any cancer diagnosis, is a major health threat – one that has potential to
shorten cancer survivors’ lives (US Department of Health and Human Services, 2014).
For this reason, there is both a research and clinical imperative to identify risk and
protective factors for smoking among cancer survivors, and to deliver evidence-based
interventions for smoking cessation to all persistent smokers (Chuang et al., 2016;
Emmons, Sprunck-Harrild, Puleo, & de Moor, 2013; NCCN, 2018). Despite strong
theoretical and conceptual models that tie causal attributions to adjustment, motivation,
and behavior change after major life events or stressors (Ajzen, 1991; Ajzen & Fishbein,
1980; Heider, 1958; Hochbaum, 1958; McBride et al., 2003; Weiner, 1985), this variable
has not received much attention in prior studies of smoking among cancer survivors.
Nonetheless, smoking-related causal attributions of cancer may help to explain why
changes in smoking behavior do or do not occur after cervical cancer diagnosis.
There is clear consensus among cancer researchers and clinicians about what tends to
cause or heighten risk for cancer, but the same cannot be said for cancer survivors
(Weinstein et al., 2005; Wold et al., 2005). For individuals with a personal cancer history,
the cause of their particular disease may be unclear, and this ambiguity leaves open the
door for causal attributions that may or may not involve personal responsibility. For
example, a cervical cancer survivor might attribute her cancer to fate, genetics, familial
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risk, HPV, smoking, some combination thereof, or none of the above. Indeed, previous
studies of causal attributions among cancer survivors have found a wide diversity of
opinion as to what causes cancer in general and what caused their cancer specifically
(Ferrucci et al., 2011; Liang et al., 2009; Lykins et al., 2008; Mullens et al., 2003;
Rodriguez et al., 2015; Torre et al., 2015; Wold et al., 2005). Of particular interest here
were the smoking-related beliefs held by cervical cancer survivors who admitted smoking
at the time of their diagnosis, with the idea being that this group might be more inclined
than the general population of cervical cancer survivors to associate smoking with
cervical cancer on both global and personal levels, ultimately raising the possibility of a
new target for smoking cessation interventions.
The first major study finding is that the majority of the sample agreed that the risk of
developing cervical cancer in general was higher among smokers than non-smokers. In
other words, cervical cancer survivors tended to endorse global attributions, something
that was evident in both questionnaire data and interview findings. The second major
finding stands in direct contrast to the first, as far fewer participants agreed that their
cervical cancer was caused by or associated with their smoking, again with consistency
across questionnaire and interview responses. Altogether, what this means is that only a
minority of cervical cancer survivors who endorsed global attributions responded in a
way that also suggested a personal attribution. Prior research that explores cervical cancer
survivors’ beliefs about smoking as a causal factor of cervical cancer in general has found
results similar to those discussed here for global attributions (Costanzo et al., 2005;
Lindau et al., 2002; Sherman, Lane, Sherman, & Lane, 2015). In addition, of the few
prior studies of personal attributions, cervical cancer survivors were more inclined to
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perceive their diagnosis as the result of HPV infection or an act of God, rather than as a
result of tobacco use (Costanzo et al., 2005; Sterba et al., 2014), which also mirrors the
findings in this study. This congruence in findings between current and past research on
the topic exist despite the fact that prior studies recruited participants with varying
smoking histories whereas this study focused exclusively on smokers at diagnosis.
Overall, it appears there is a clear disconnect between the global and personal smokingrelated causal attributions made by cervical cancer survivors.
As a whole, the causal attribution study findings suggest cervical cancer survivors may
not have a full understanding of or appreciation for the role of smoking in cervical cancer
risk (or prognosis). This is highlighted by the fact that interview participants frequently
made mention of the strong, positive link between smoking and cancer in general as well
as lung and head/neck cancers specifically, with fewer or weaker comments on the link
between smoking and cervical cancer. Similar results of inexact knowledge or
misunderstanding of smoking-related cancers are documented in other tobacco-related
cancer samples, but most of this work is limited to lung and head/neck cancer
(Christensen et al., 1999; Salander, 2007). The results of data analysis pertinent to the
second study aim point toward a positive, albeit possibly weak, association between
causal attributions and current smoking status and intentions to abstain in the future.
Preliminary findings from the questionnaire responses are indicative of some knowledge,
but not strong support, of smoking-related causal beliefs. Interview data further illustrates
this, as there was a clear difference in causal attribution endorsement among former
versus current smokers. Beyond cancer samples, similar knowledge and attribution trends
exist in HIV/AIDS patients who continue to smoke after diagnosis despite warnings of
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poor immune response (Shuter et al., 2017) and long-term drinkers who continue to
consume alcohol in excess despite warnings of poor health (Cotter, Perez, Dunlop, Kite,
& Gaskin, 2013). As a whole, this body of research underscores the role that causal
attributions play in health behavior performance and change across disease populations.
With a focus on the apparent discrepancy between global and personal attributions, a
grim interpretation of the findings would indicate that the prevailing education-related
cancer prevention and control efforts are inadequate, but that is likely too simplistic of an
explanation. At least two other explanations exist. First, it is still common for cancer
survivors to encounter disease-related stigma, particularly with cancer types typically
associated with one’s own behavior (e.g., lung cancer and smoking, cervical cancer and
sexually transmitted diseases) (Brown, Brodsky, & Cataldo, 2014; Hamann, Shen,
Thomas, Lee, & Ostroff, 2017; Lebel et al., 2013; Lebel & Devins, 2008; Luberto,
Hyland, Streck, Temel, & Park, 2016). For those who do perceive cancer-related stigma,
other negative social and personal outcomes can co-occur, including the experience of
social constraints and feelings of embarrassment and shame (Chambers et al., 2015; ElseQuest & Jackson, 2014; Hamann et al., 2014; Hamann, Ver Hoeve, Carter-Harris, Studts,
& Ostroff, 2018; Lebel et al., 2013; LoConte et al., 2008; Marlow, Waller, & Wardle,
2010). For cancer survivors who smoke, the source of stigma could be twofold, as it
could stem from the cancer diagnosis itself and others’ perception that the disease was
self-induced or within the survivor’s control (Else-Quest & Jackson, 2014; Else-Quest,
LoConte, Schiller, & Hyde, 2009; Weiner, 1993). The experience of stigma and
associated negative outcomes may prompt some cancer survivors to adopt a defensive
coping strategy such as minimizing the contribution that their behavior may have played
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in their cancer and instead espousing alternative cancer attributions (Malcarne, Compas,
Epping-Jordan, & Howell, 1995; McBride et al., 2003; A. Price et al., 2012). In sum, the
perception of and response to stigma could help explain why cervical cancer survivors in
this study tended to endorse global, but not personal smoking-related causal attributions.
Second, fatalistic beliefs (i.e., a perception that life/health events are out of one’s own
control and unavoidable) in general or about cancer specifically also might explain the
relatively low endorsement of personal attributions in this study, as they are commonly
cited in other studies with cancer survivors (Befort, Nazir, Engelman, & Choi, 2013;
Costanzo et al., 2005; Lykins et al., 2008; McBride & Ostroff, 2003; Rodriguez et al.,
2015; Sterba et al., 2014). Regardless of the reason, if cervical cancer survivors disregard,
minimize, or are unaware of the causal association between smoking and cervical cancer,
it is likely they will not perceive continued smoking as an ongoing health risk, and as a
result, their smoking behavior may not change.
This brings up the third major finding of this study, which is that the rate of current
smoking in this sample (80%) is higher than what is already documented for cervical
cancer survivors (typically, 40-50%) (Brinton et al., 1986; CDC, 2018; Coker,
DeSimone, Eggleston, et al., 2009; Coups & Ostroff, 2005; Marteau et al., 2002; Mayer
& Carlson, 2011; Plummer et al., 2003; Roura et al., 2014; Schlumbrecht, Sun, Huang,
Zandstra, & Bodurka, 2014b) plus the rates found amongst other smoking-related cancer
survivors (Berg, Carpenter, Jardin, & Ostroff, 2013; Burris, Studts, De Rosa, & Ostroff,
2015; Coups & Ostroff, 2005), as well recent estimates of smoking in the general
population of US women (14%) (CDC, 2015). However, two important methodological
differences exist across these studies/estimates. First, other samples reflect greater
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heterogeneity in terms of their sociodemographic and geographic composition whereas
this sample is largely comprised of socioeconomically disadvantaged women who live in
rural areas. Second, most other studies survey cancer survivors in general and do not
report prevalence rates for current smoking by smoking history at diagnosis (i.e., never,
former, or current) (Brown et al., 2014; Burris, Studts, et al., 2015; Land et al., 2016;
Mayer & Carlson, 2011) while this study targeted cancer survivors who were current
smokers at diagnosis. Remarkably, this study aimed first to enroll women of low
socioeconomic status, as the burden of cervical cancer is greatest in this population
(Akinlotan et al., 2017; Hopenhayn et al., 2008) and the generalizability of the findings
are therefore more pronounced, and second to enroll women at greatest risk for continued
smoking (Burris, Studts, et al., 2015), as the resultant findings were thought to be critical
to development of more effective smoking cessation interventions for cancer survivors as
a whole (Nayan, Gupta, Strychowsky, & Sommer, 2013). Nonetheless, this sampling
strategy led to a sample of cervical cancer survivors that is potentially at heightened risk
for smoking after cancer diagnosis.
Closely considering the smoking and quitting behavior of cervical cancer survivors in this
study, several findings warrant comment. First, among current smokers, nicotine
dependence in the sample was moderate, as indicated by the typical time to first cigarette
(i.e., within 30 minutes of waking) and average number of cigarettes per day (i.e.,
roughly ¾ of a pack). Prior research demonstrates that factors related to smoking
cessation in the general population also hold true in cancer populations (e.g., the role of
motivation and confidence in quit attempts (Biener & Hargraves, 2015; Burris et al.,
2016; Schnoll et al., 2013), so it remains imperative to address nicotine dependence,
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withdrawal, craving and the like in any smoking cessation intervention for cancer
survivors (Cooley et al., 2013; Ostroff et al., 2014; S. Price et al., 2017). Second, nearly
half of current smokers reported “dual use,” that is the use of conventional cigarettes
alongside either e-cigarettes or cigars. Interestingly, former smokers reported lifetime,
but not current, use of an alternative tobacco product, suggesting an encouraging trend of
total product cessation and abstinence. A paucity of studies has explored alternative
tobacco product use in cancer survivors (for exceptions, see (Berg et al., 2013; Borderud,
Li, Burkhalter, Sheffer, & Ostroff, 2014), but the current study suggests it may be
important to do so in the future. Third, a majority of the total sample reported at least one
lifetime quit attempt, with more than half (60%) attempting cessation after diagnosis.
Despite low direct endorsement of smoking-related causal attributions in the sample, this
finding may demonstrate a more generic association between cancer diagnosis and
smoking behavior. Fourth, regarding treatment use, former smokers mostly quit
unassisted and supported a “cold turkey” approach, while current smokers expressed
more openness to help with smoking cessation, which may be a function of their
frustration with “failed” quit attempts. Prior research has found few cancer survivors seek
help with smoking cessation (Dahm et al., 2009; Medbø, Melbye, & Rudebeck, 2011;
Miele et al., 2018; Morphett, Partridge, Gartner, Carter, & Hall, 2015; Schnoll et al.,
2013), so it is encouraging that many of the current smokers who recently made quit
attempts opted to use nicotine replacement or another evidence-based treatment. That
said, most of the cervical cancer survivors in this study are burdened by low
socioeconomic status, which may negatively impact their long-term access to highquality and timely healthcare, inclusive of smoking cessation treatments (Cooper,
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Borland, & Yong, 2011; Kruger et al., 2012). Fifth, the high rate of current smoking may
be the result of the unfortunate combination of low motivation and confidence to quit,
making it important to highlight that there exist proven interventions to boost smokers’
motivation and confidence to quit (Burris, Heckman, Mathew, & Carpenter, 2015;
Hettema & Hendricks, 2010; Lundahl et al., 2013). Given all of the above, there seems to
exist great need for targeted, if not tailored, interventions for cervical cancer survivors
who smoke.
The methodological strengths and weaknesses of this mixed-method pilot study deserve
comment. First and foremost, this study is the first to describe the smoking behaviors of
cervical cancer survivors in any detail, which is a necessary first step toward
development of tailored interventions for this high-risk group of cancer survivors. Prior
tobacco use studies in this population generally provide point prevalence estimates of
smoking with little or no comment on product type(s), frequency, quantity, or nicotine
dependency, and only limited information about quit attempt history (Hopenhayn,
Christian, Christian, Studts, & Mullet, 2013; Schlumbrecht et al., 2014b). Given that
prior US population-based studies show cervical cancer survivors to smoke at a rate that
exceeds both women in the general population and other cancer survivor groups (Iyer et
al., 2016; Shoemaker, White, Hawkins, & Hayes, 2016; Underwood et al., 2012), it is
important to understand their unique smoking and quitting experience. Second, cervical
cancer survivors – which represent an understudied population – are typically considered
vulnerable and hard-to-reach (Freeman & Wingrove, 2005; Nayan et al., 2013).
Consequently, the recruitment efforts of this study, which included partnering with a
community-based organization that serves under-insured and poor cancer survivors, is a
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strength as it allowed the enrollment of women who truly reflect the larger population of
interest. Finally, and related to the above point, this study utilized a combination of
population-based and purposive recruitment strategies in an attempt to obtain a
representative sample.
Of course, this study is not without limitations. The first limitation is the size of the
sample and the fact that it is homogenous in terms of demographic variables of race and
ethnicity. These two factors likely limit generalizability of the findings to Caucasian,
non-Hispanic women, which is an important consideration given that nationwide, cervical
cancer is more common among women of African American and Hispanic heritage (U.S.
Cancer Statistics Working Group, 2015) . That said, the sample is representative of the
state from which it was drawn (Kentucky Cancer Registry, 2017), which is largely white
and non-Hispanic. Second, at the point of contact by the two recruitment sources, the
rates of acceptance for study interest were modest (34-50%). This might be due to the
manner in which research procedures, costs, and benefits were described by the two
recruitment sources, but by and large, the overall accrual rate is consistent with prior
studies that used state registries to identify participants (Burris & Andrykowski, 2010;
Coker, DeSimone, Eggleston, et al., 2009; Keegan et al., 2013; Vadaparampil et al.,
2012). Furthermore, the rates of acceptance for study participation once eligibility was
determined by study personnel was very high (91-92%), which speaks to the feasibility of
accrual once the population is identified. A third limitation is reliance on self-report for
smoking and other tobacco use status, as this study did not use biochemical verification
to confirm reports of abstinence. However, smoking rates in the sample were so high that
there is little reason to believe that participants misrepresented their tobacco use
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behaviors. Furthermore, this approach is not without precedent in other observational
studies with cancer survivors (Glasgow et al., 1993; Studts et al., 2006; Wong, Shields,
Leatherdale, Malaison, & Hammond, 2012). Fourth, given that some participants were
asked to reflect upon and report their experiences and behavior in the five years before
data collection (i.e., from diagnosis to date), some of the results are subject to
retrospective bias. However, the primary outcomes of interest (i.e., causal attributions and
current smoking behaviors) were present-focused outcomes. Finally, not all 50
participants chose to complete an interview, and the findings of the 21 who did may or
may not be representative of the full sample or of all cervical cancer survivors. Therefore,
it is important to note that post hoc analyses that compared interview and non-interview
participants on all demographic and clinical variables (as well as the prevalence of
current smoking) yielded no significant differences between groups (data not shown),
suggesting that at least within the sample herein, the findings likely generalize. In
conclusion, despite its limitations, this study is a significant contribution to the sparse
literature on causal attributions and smoking behaviors of cervical and potentially other
smoking-related cancer survivors.
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